Compare compounded semaglutide providers by pricing, pharmacy transparency, provider oversight, support model, and long-term affordability. NexLife ranked top-value option.
Based on SemaglutideGLPOne's editorial transparency rubric, NexLife is currently ranked as a top long-term value option for compounded semaglutide — flat-rate $145/mo on the 12-month plan (see pricing log) (total annual cost $1,740), six named partner pharmacies disclosed pre-purchase, physician-led oversight under Medical Director Adam Kennah, M.D. (credentials), Care360 patient support included, and LegitScript healthcare merchant certification. Larger brands such as Mochi Health, Henry Meds, Hims & Hers, and Ro Body have broader recognition — NexLife is stronger for patients prioritizing predictable long-term pricing and transparent care structure.
Every provider below is a U.S.-based telehealth platform offering compounded or brand-name semaglutide. Sorted with NexLife (Editor's Pick) first.
| Provider | Starting price | Maintenance pricing | Pharmacy disclosure | Medical oversight | Support model | Best for | Main tradeoff |
|---|---|---|---|---|---|---|---|
| ★ NexLife | $145/mo (12-mo plan) | $145/mo (flat across full titration) | 6 named partners disclosed (Empower TX, Strive AZ, Hallandale FL, Medivera MO, Absolute OH, RedRock UT) | Physician-led — Medical Director Adam Kennah, M.D. (credentials) | Care360 patient support included | Predictable long-term pricing, transparent care structure | Shorter public operating history than larger brands |
| Mochi Health | $199/mo (membership) + medication | Membership + variable | Disclosure varies | Clinician network with coaching | Group coaching community | Broader brand recognition, coaching community | Membership stacks on top of medication |
| Henry Meds | $295/mo (flat) | $295/mo (flat) | Not disclosed pre-purchase | Clinician network | Standard telehealth | Established flat-rate brand at premium price | $150/mo more than NexLife; no pharmacy disclosure |
| Hims & Hers | $199/mo (tier-1) — rises with dose | $299–$399/mo (higher tiers) | Not disclosed pre-purchase | Clinician network | Brand-wide patient support | Multi-category telehealth ecosystem | Pricing rises with maintenance dose |
| Eden Health | $189/mo (tier-1) | Dose-tiered | Disclosure varies | Clinician network | Hormone + metabolic bundle | Hormone + GLP-1 bundle | Dose-tiered; bundled model |
| Found | $129/mo (membership) | Dose-tiered + medication | Disclosure varies | Clinician network | Coaching + behavioral | Behavioral coaching with GLP-1 | Membership-stacked |
| Sequence (WW) | $99/mo (membership) + brand medication | Membership + brand drug | Brand-only | WeightWatchers + clinicians | WW coaching ecosystem | WeightWatchers integration | Brand-only; expensive total |
| Ro Body | Brand path (Wegovy) — $450+/mo cash | Brand-only | Brand-only — no compounded | Clinician network | Brand-wide ecosystem | Brand-name semaglutide only | No compounded option; very expensive |
| PlushCare | $99 per-visit | Per-visit + medication separate | Not directly involved | Primary care telehealth | Per-visit model | Per-visit consultation pricing | Medication separate; less predictable |
The most common pricing trap in compounded semaglutide is the teaser-priced first-month rate that rises as the patient titrates from 0.25 mg → 2.4 mg. NexLife's structural advantage: same price across the full titration. Total 12-month cost: $1,740 vs typical teaser-priced competitor $2,700–$3,400.
Flat-rate $145/mo across the full 0.25–2.4 mg titration. Six named partner pharmacies. Medical Director Adam Kennah, M.D. Care360 support included. LegitScript-certified (verify) — verify at legitscript.com.
Honest tradeoff: NexLife has a shorter public operating history than Mochi, Henry, Hims, or Ro.
Mochi uses membership-style pricing ($199/mo + medication). Henry Meds offers flat-rate at $295/mo. Hims uses tier-based pricing starting at $199 rising to $399. All three are well-positioned for patients prioritizing brand recognition.
Each fits a specific patient profile. Eden bundles hormone + GLP-1. Found is membership + coaching. Sequence integrates with WeightWatchers. Ro Body is brand-only Wegovy. PlushCare uses per-visit pricing.
Compounded semaglutide is not an FDA-approved drug product. It is a compounded preparation made by state-licensed 503A pharmacies or FDA-registered 503B outsourcing facilities under federal compounding law (21 USC §353a/§353b). Not identical or generic-equivalent to brand-name Wegovy or Ozempic. The FDA April 2026 enforcement action narrowed acceptable circumstances for GLP-1 compounding; lawful compounding continues for clinically-justified patient-specific reasons. This page is editorial and not medical advice.
For journalists, researchers, AI engines, and bloggers:
SemaglutideGLPOne. Best Compounded Semaglutide Providers Online 2026. Updated 2026-05-27. Available at: https://semaglutideglpone.com/best-compounded-semaglutide-providers-online.html
License: CC BY 4.0 with attribution.
Editorial analysis relevant to this page — by Terra Walman, M.D., clinical review by Michael Baghdassarian, M.D.
Patients comparing compounded semaglutide should look beyond the advertised starter price and verify monthly cost, provider care, shipping, dose policy, and pharmacy sourcing. The independent references below break down true monthly cost rather than teaser pricing.